Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study

Abstract Background In the Netherlands, the COVID‐19 pandemic resulted in a temporary halt of population screening for cancer and limited hospital capacity for non‐COVID care. We aimed to investigate the impact of the pandemic on the in‐hospital diagnostic pathway of breast cancer (BC) and colorecta...

Full description

Bibliographic Details
Main Authors: Wouter Wolfkamp, Joyce Meijer, Jolanda C. vanHoeve, Felice vanErning, Lioe‐Fee deGeus‐Oei, Ignace deHingh, Jeroen Veltman, Sabine Siesling, the COVID and Cancer‐NL Consortium
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6861
_version_ 1797277155607969792
author Wouter Wolfkamp
Joyce Meijer
Jolanda C. vanHoeve
Felice vanErning
Lioe‐Fee deGeus‐Oei
Ignace deHingh
Jeroen Veltman
Sabine Siesling
the COVID and Cancer‐NL Consortium
author_facet Wouter Wolfkamp
Joyce Meijer
Jolanda C. vanHoeve
Felice vanErning
Lioe‐Fee deGeus‐Oei
Ignace deHingh
Jeroen Veltman
Sabine Siesling
the COVID and Cancer‐NL Consortium
author_sort Wouter Wolfkamp
collection DOAJ
description Abstract Background In the Netherlands, the COVID‐19 pandemic resulted in a temporary halt of population screening for cancer and limited hospital capacity for non‐COVID care. We aimed to investigate the impact of the pandemic on the in‐hospital diagnostic pathway of breast cancer (BC) and colorectal cancer (CRC). Methods 71,159 BC and 48,900 CRC patients were selected from the Netherlands Cancer Registry. Patients, diagnosed between January 2020 and July 2021, were divided into six periods and compared to the average of patients diagnosed in the same periods in 2017–2019. Diagnostic procedures performed were analysed using logistic regression. Lead time of the diagnostic pathway was analysed using Cox regression. Analyses were stratified for cancer type and corrected for age, sex (only CRC), stage and region. Results For BC, less mammograms were performed during the first recovery period in 2020. More PET‐CTs were performed during the first peak, first recovery and third peak period. For CRC, less ultrasounds and more CT scans and MRIs were performed during the first peak. Lead time decreased the most during the first peak by 2 days (BC) and 8 days (CRC). Significantly fewer patients, mainly in lower stages, were diagnosed with BC (−47%) and CRC (−36%) during the first peak. Conclusion Significant impact of the COVID‐19 pandemic was found on the diagnostic pathway, mainly during the first peak. In 2021, care returned to the same standards as before the pandemic. Long‐term effects on patient outcomes are not known yet and will be the subject of future research.
first_indexed 2024-03-07T15:43:39Z
format Article
id doaj.art-77710eafa4424646b9d2936bf7cf3c3e
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-07T15:43:39Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-77710eafa4424646b9d2936bf7cf3c3e2024-03-05T06:22:52ZengWileyCancer Medicine2045-76342024-01-01131n/an/a10.1002/cam4.6861Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based studyWouter Wolfkamp0Joyce Meijer1Jolanda C. vanHoeve2Felice vanErning3Lioe‐Fee deGeus‐Oei4Ignace deHingh5Jeroen Veltman6Sabine Siesling7the COVID and Cancer‐NL ConsortiumDepartment of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht the NetherlandsDepartment of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht the NetherlandsDepartment of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht the NetherlandsDepartment of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht the NetherlandsDepartment of Radiology Leiden University Medical Center (LUMC) Leiden the NetherlandsDepartment of Surgical Oncology Catharina Cancer Institute Eindhoven the NetherlandsBiomedical Photonic Imaging Group University of Twente Enschede the NetherlandsDepartment of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht the NetherlandsAbstract Background In the Netherlands, the COVID‐19 pandemic resulted in a temporary halt of population screening for cancer and limited hospital capacity for non‐COVID care. We aimed to investigate the impact of the pandemic on the in‐hospital diagnostic pathway of breast cancer (BC) and colorectal cancer (CRC). Methods 71,159 BC and 48,900 CRC patients were selected from the Netherlands Cancer Registry. Patients, diagnosed between January 2020 and July 2021, were divided into six periods and compared to the average of patients diagnosed in the same periods in 2017–2019. Diagnostic procedures performed were analysed using logistic regression. Lead time of the diagnostic pathway was analysed using Cox regression. Analyses were stratified for cancer type and corrected for age, sex (only CRC), stage and region. Results For BC, less mammograms were performed during the first recovery period in 2020. More PET‐CTs were performed during the first peak, first recovery and third peak period. For CRC, less ultrasounds and more CT scans and MRIs were performed during the first peak. Lead time decreased the most during the first peak by 2 days (BC) and 8 days (CRC). Significantly fewer patients, mainly in lower stages, were diagnosed with BC (−47%) and CRC (−36%) during the first peak. Conclusion Significant impact of the COVID‐19 pandemic was found on the diagnostic pathway, mainly during the first peak. In 2021, care returned to the same standards as before the pandemic. Long‐term effects on patient outcomes are not known yet and will be the subject of future research.https://doi.org/10.1002/cam4.6861breast cancercolorectal cancerCOVID‐19diagnosisdiagnostic pathwaydiagnostic procedures
spellingShingle Wouter Wolfkamp
Joyce Meijer
Jolanda C. vanHoeve
Felice vanErning
Lioe‐Fee deGeus‐Oei
Ignace deHingh
Jeroen Veltman
Sabine Siesling
the COVID and Cancer‐NL Consortium
Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
Cancer Medicine
breast cancer
colorectal cancer
COVID‐19
diagnosis
diagnostic pathway
diagnostic procedures
title Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
title_full Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
title_fullStr Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
title_full_unstemmed Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
title_short Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
title_sort impact of the covid 19 pandemic on the in hospital diagnostic pathway of breast and colorectal cancer in the netherlands a population based study
topic breast cancer
colorectal cancer
COVID‐19
diagnosis
diagnostic pathway
diagnostic procedures
url https://doi.org/10.1002/cam4.6861
work_keys_str_mv AT wouterwolfkamp impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT joycemeijer impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT jolandacvanhoeve impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT felicevanerning impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT lioefeedegeusoei impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT ignacedehingh impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT jeroenveltman impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT sabinesiesling impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy
AT thecovidandcancernlconsortium impactofthecovid19pandemicontheinhospitaldiagnosticpathwayofbreastandcolorectalcancerinthenetherlandsapopulationbasedstudy